baclofen has been researched along with Pyrexia in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baclofen withdrawal syndrome is a rare and potentially life-threatening condition manifesting with autonomic dysreflexia, high fevers, spasticity, seizures, and multiorgan failure." | 7.76 | Reversible electrocardiogram changes and cardiomyopathy secondary to baclofen withdrawal syndrome. ( Kireyev, D; Poh, KK, 2010) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 7.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| " The patient continued to have fever and autonomic instability without evidence of infection which entirely resolved within 24 hours of reinstitution of full preadmission dosing of oral baclofen." | 5.33 | Baclofen withdrawal: a cause of prolonged fever in the intensive care unit. ( Cunningham, JA; Jelic, S, 2005) |
| "Baclofen (Lioresal) is a drug of choice to treat spasticity and is increasingly being administered intrathecally via an implantable pump in cases refractory to oral therapy." | 5.32 | Intrathecal baclofen withdrawal mimicking sepsis. ( Amin, Y; Kao, LW; Kirk, MA; Turner, MS, 2003) |
| " He developed acute kidney injury at hospital secondary to vancomycin use, and mental status declined." | 5.05 | Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature. ( Abraham, M; Behmer Hansen, R; Gold, J; Lad, M; Mammis, A; Zhao, K, 2020) |
| " Syndromes include adrenergic "fever," anticholinergic "fever," antidopaminergic "fever," serotonin syndrome, malignant hyperthermia, uncoupling of oxidative phosphorylation, and withdrawal from baclofen." | 4.86 | Adverse drug reactions resulting in hyperthermia in the intensive care unit. ( McAllen, KJ; Schwartz, DR, 2010) |
| "We report a case of a 53-year-old woman who presented initially with sepsis and later in her stay developed a severe and rapidly progressing hyperthermia after a decrease in oral baclofen dosage." | 3.96 | Severe hyperthermia due to oral baclofen withdrawal. ( Kim, E; Nadherny, W; Paul, V; Righter, K, 2020) |
| "Baclofen withdrawal syndrome is a rare and potentially life-threatening condition manifesting with autonomic dysreflexia, high fevers, spasticity, seizures, and multiorgan failure." | 3.76 | Reversible electrocardiogram changes and cardiomyopathy secondary to baclofen withdrawal syndrome. ( Kireyev, D; Poh, KK, 2010) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 3.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| "Rapid baclofen withdrawal is known to cause markedly increased spasticity, but high fever associated with this complication has not been reported." | 3.68 | Hyperthermia associated with baclofen withdrawal and increased spasticity. ( Hurvitz, EA; Mandac, BR; Nelson, VS, 1993) |
| "Hiccups are involuntary diaphragmatic muscle contractions with early glottis closure terminating inspiration." | 1.62 | Persistent hiccup: A rare presentation of COVID-19. ( Bakheet, N; El-Shazly, M; Fouad, R; Hussin, W; Kassem, AM, 2021) |
| " The patient continued to have fever and autonomic instability without evidence of infection which entirely resolved within 24 hours of reinstitution of full preadmission dosing of oral baclofen." | 1.33 | Baclofen withdrawal: a cause of prolonged fever in the intensive care unit. ( Cunningham, JA; Jelic, S, 2005) |
| "Baclofen (Lioresal) is a drug of choice to treat spasticity and is increasingly being administered intrathecally via an implantable pump in cases refractory to oral therapy." | 1.32 | Intrathecal baclofen withdrawal mimicking sepsis. ( Amin, Y; Kao, LW; Kirk, MA; Turner, MS, 2003) |
| " Overall, the data obtained here suggest that positive modulation of GABAB receptors may serve as a novel therapeutic strategy for the development of anxiolytics, with a superior side effect profile to both baclofen and benzodiazepines." | 1.32 | Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. ( Bettler, B; Chaperon, F; Cryan, JF; Froestl, W; Gentsch, C; Kaupmann, K; Kelly, PH; Lingenhoehl, K; Mombereau, C; Spooren, WP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, J | 1 |
| Zhao, K | 1 |
| Abraham, M | 1 |
| Behmer Hansen, R | 1 |
| Lad, M | 1 |
| Mammis, A | 1 |
| Paul, V | 1 |
| Righter, K | 1 |
| Kim, E | 1 |
| Nadherny, W | 1 |
| Bakheet, N | 1 |
| Fouad, R | 1 |
| Kassem, AM | 1 |
| Hussin, W | 1 |
| El-Shazly, M | 1 |
| Sengupta, D | 1 |
| Kapoor, I | 1 |
| Mahajan, C | 1 |
| Prabhakar, H | 1 |
| Sweeney, FF | 1 |
| O'Leary, OF | 1 |
| Cryan, JF | 3 |
| Li, X | 1 |
| Kaczanowska, K | 1 |
| Finn, MG | 1 |
| Markou, A | 1 |
| Risbrough, VB | 1 |
| Huang, YS | 1 |
| Hsiao, MC | 1 |
| Lee, M | 1 |
| Huang, YC | 1 |
| Lee, JD | 1 |
| McAllen, KJ | 1 |
| Schwartz, DR | 1 |
| Kireyev, D | 1 |
| Poh, KK | 1 |
| Wang, YY | 1 |
| Qin, J | 1 |
| Han, Y | 1 |
| Cai, J | 1 |
| Xing, GG | 1 |
| Alden, TD | 1 |
| Lytle, RA | 1 |
| Park, TS | 1 |
| Noetzel, MJ | 1 |
| Ojemann, JG | 1 |
| Meythaler, JM | 1 |
| Roper, JF | 1 |
| Brunner, RC | 1 |
| Kao, LW | 1 |
| Amin, Y | 1 |
| Kirk, MA | 1 |
| Turner, MS | 1 |
| Kelly, PH | 1 |
| Chaperon, F | 1 |
| Gentsch, C | 1 |
| Mombereau, C | 1 |
| Lingenhoehl, K | 1 |
| Froestl, W | 1 |
| Bettler, B | 1 |
| Kaupmann, K | 1 |
| Spooren, WP | 1 |
| Cunningham, JA | 1 |
| Jelic, S | 1 |
| Jacobson, LH | 1 |
| Pirovino, M | 1 |
| Meier, J | 1 |
| Meyer, M | 1 |
| Waldmeier, P | 1 |
| Schmid, M | 1 |
| Khorasani, A | 1 |
| Peruzzi, WT | 1 |
| Mandac, BR | 1 |
| Hurvitz, EA | 1 |
| Nelson, VS | 2 |
| Grenier, B | 1 |
| Mesli, A | 1 |
| Cales, J | 1 |
| Castel, JP | 1 |
| Maurette, P | 1 |
| Reeves, RK | 1 |
| Stolp-Smith, KA | 1 |
| Christopherson, MW | 1 |
| Green, LB | 1 |
| Wu, SS | 1 |
| Dolan, KA | 1 |
| Michael Ferrante, F | 1 |
4 reviews available for baclofen and Pyrexia
| Article | Year |
|---|---|
Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Baclofen; Brain Diseases; Electroencephalography; | 2020 |
Adverse drug reactions resulting in hyperthermia in the intensive care unit.
Topics: Baclofen; Critical Care; Drug-Related Side Effects and Adverse Reactions; Fever; Humans; Intensive C | 2010 |
Intrathecal baclofen withdrawal: a case report and review of the literature.
Topics: Adolescent; Adrenoleukodystrophy; Baclofen; Equipment Failure; Fever; Humans; Infusion Pumps, Implan | 2002 |
Death after acute withdrawal of intrathecal baclofen: case report and literature review.
Topics: Administration, Oral; Adult; Baclofen; Brain Death; Cervical Vertebrae; Equipment Failure; Fatal Out | 1999 |
19 other studies available for baclofen and Pyrexia
| Article | Year |
|---|---|
Severe hyperthermia due to oral baclofen withdrawal.
Topics: Administration, Oral; Baclofen; Dose-Response Relationship, Drug; Female; Fever; Humans; Middle Aged | 2020 |
Persistent hiccup: A rare presentation of COVID-19.
Topics: Baclofen; Biomarkers; COVID-19; COVID-19 Testing; Fever; Hiccup; Humans; Hydroxychloroquine; Male; M | 2021 |
Baclofen for neurogenic fever in a patient with cerebral contusion.
Topics: Adult; Baclofen; Brain Contusion; Fever; GABA-B Receptor Agonists; Humans; Male; Treatment Outcome; | 2019 |
Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anxiety; Baclofen; Benzylamines; Defense Mechanisms | 2014 |
The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Baclofen; Buspirone; Conditioning, Classical; Dose-Response R | 2015 |
Baclofen successfully abolished prolonged central hyperthermia in a patient with basilar artery occlusion.
Topics: Aged; Baclofen; Body Temperature Regulation; Brain Stem; Female; Fever; Humans; Stroke; Vertebrobasi | 2009 |
Reversible electrocardiogram changes and cardiomyopathy secondary to baclofen withdrawal syndrome.
Topics: Adult; Autonomic Dysreflexia; Baclofen; Bundle-Branch Block; Electrocardiography; Fever; GABA-B Rece | 2010 |
Hyperthermia induces epileptiform discharges in cultured rat cortical neurons.
Topics: Action Potentials; Animals; Baclofen; Cells, Cultured; Cerebral Cortex; Fever; Fluorescent Antibody | 2011 |
Cyproheptadine for intrathecal baclofen withdrawal.
Topics: Acute Disease; Adult; Baclofen; Cerebral Palsy; Cyproheptadine; Diagnosis, Differential; Female; Fev | 2003 |
Intrathecal baclofen withdrawal mimicking sepsis.
Topics: Baclofen; Child, Preschool; Clinical Protocols; Decerebrate State; Diagnosis, Differential; Emergenc | 2003 |
Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Baclofen; Benzodiazepines; Body Temperature; Cyclo | 2004 |
Baclofen withdrawal: a cause of prolonged fever in the intensive care unit.
Topics: Adult; Baclofen; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Fever; Humans; I | 2005 |
Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Baclofen; Behavior, Animal; Benzodiazepines; Body Temperature | 2008 |
[Malignant neuroleptics syndrome].
Topics: Adult; Amantadine; Baclofen; Cerebrospinal Fluid; Chromatography, Liquid; Cognition Disorders; Femal | 1984 |
Dantrolene treatment for abrupt intrathecal baclofen withdrawal.
Topics: Adult; Baclofen; Dantrolene; Fever; Humans; Male; Muscle Spasticity; Spinal Cord Injuries; Substance | 1995 |
Hyperthermia associated with baclofen withdrawal and increased spasticity.
Topics: Adolescent; Baclofen; Fever; Humans; Male; Muscle Spasticity; Quadriplegia; Substance Withdrawal Syn | 1993 |
[Severe hyperthermia caused by sudden withdrawal of continuous intrathecal administration of baclofen].
Topics: Adult; Baclofen; Fever; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; Muscle Hypoto | 1996 |
Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure.
Topics: Adult; Baclofen; Catheters, Indwelling; Dantrolene; Disseminated Intravascular Coagulation; Equipmen | 1998 |
Febrile reaction to subarachnoid baclofen administration.
Topics: Adult; Baclofen; Drug Delivery Systems; Drug Implants; Female; Fever; GABA Agonists; Humans; Injecti | 2002 |